Prospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1098-1105
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1098
Table 5 Patients’ satisfaction through active monitoring and intervention by endoscopist during colonoscopy
Active monitoring (n = 39)Non-active monitoring (n = 128)P value
Sex (Male, %)19 (48.7)70 (54.7)0.584
Age (mean ± SD)56.1 ± 13.057.7 ± 13.50.514
Proportion of EMR, n (%)32 (82.1)51 (39.8)< 0.001
Satisfaction, n (%)0.968
Very satisfied12 (30.8)39 (30.5)
Satisfied20 (51.3)66 (51.6)
Fair5 (12.8)14 (10.9)
Unsatisfied2 (5.1)9 (7.0%)
Midazolam, first dose (mg, mean ± SD)4.5 ± 1.04.2 ± 0.90.159
Midazolam, total dose (mg, mean ± SD)5.8 ± 1.24.8 ± 1.50.002
Midazolam, No. of injections (mean ± SD)1.6 ± 0.51.4 ± 0.70.025
Procedure time (min, mean ± SD)28.8 ± 12.222.3 ± 12.20.005